Amgen Inc. buy Cantor Fitzgerald
Start price
22.10.24
/
50%
€293.20
Target price
22.10.25
€374.67
Performance (%)
-13.06%
End price
23.10.25
€254.90
Summary
This prediction ended on 23.10.25 with a price of €254.90. The price of Amgen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.06%. Dividends of €9.15 are taken into consideration when calculating the performance. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -2.306% | -2.306% | 17.415% |
| iShares Core DAX® | -1.424% | 8.918% | 7.311% |
| iShares Nasdaq 100 | 3.274% | 16.275% | 36.651% |
| iShares Nikkei 225® | 1.745% | 16.239% | 46.602% |
| iShares S&P 500 | 1.447% | 10.913% | 27.166% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $405.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten